BioRestorative Therapies (BRTX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $1.46, -2.67% vs the prior close of $1.50.
- Volume 27.80K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BRTX dips 2.7% to $1.46, a 1-month low, 4 down days in a row. Closed at $1.46, -2.67% vs the prior close of $1.50. Day range $1.28–$1.50, opened at $1.50.
BRTX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — BRTX dips 2.7% to $1.46, a 1-month low, 4 down days in a row
- Closed at $1.46, -2.67% vs the prior close of $1.50. Day range $1.28–$1.50, opened at $1.50.
- Volume was 27.80K shares, 0.1x its 50-day average of 185.92K — lighter than usual.
- Price is -2.9% vs its 50-day average ($1.50) and +92.1% vs its 200-day average ($0.76).
- 52-week range $0.14–$5.67; today's close sits at 24% of that range, 74.2% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — BRTX slides 5.7% to $1.50, a 1-month low, 3 down days in a row
- Closed at $1.50, -5.66% vs the prior close of $1.59. Day range $1.42–$1.56, opened at $1.50.
- Volume was 18.30K shares, 0.1x its 50-day average of 199.18K — lighter than usual.
- Price is -3.7% vs its 50-day average ($1.56) and +97.8% vs its 200-day average ($0.76).
- 52-week range $0.14–$5.67; today's close sits at 25% of that range, 73.5% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — BRTX slides 9.1% to $1.59, a 1-month low
- Closed at $1.59, -9.14% vs the prior close of $1.75. Day range $1.44–$1.71, opened at $1.70.
- Volume was 32.40K shares, 0.1x its 50-day average of 217.16K — lighter than usual.
- Price is +3.8% vs its 50-day average ($1.53) and +110.1% vs its 200-day average ($0.76).
- 52-week range $0.14–$5.67; today's close sits at 26% of that range, 71.9% below the 52-week high.
Oct 12, 2026 — BRTX slides 8.4% to $1.75, a 1-month low
- Closed at $1.75, -8.38% vs the prior close of $1.91. Day range $1.70–$1.90, opened at $1.85.
- Volume was 11.40K shares, 0.0x its 50-day average of 229.53K — lighter than usual.
- Price is +16.4% vs its 50-day average ($1.50) and +131.9% vs its 200-day average ($0.75).
- 52-week range $0.14–$5.67; today's close sits at 29% of that range, 69.1% below the 52-week high.
Oct 9, 2026 — BRTX rises 1.1% to $1.91
- Closed at $1.91, +1.06% vs the prior close of $1.89. Day range $1.85–$1.95, opened at $1.92.
- Volume was 18.40K shares, 0.1x its 50-day average of 229.93K — lighter than usual.
- Price is +29.6% vs its 50-day average ($1.47) and +154.1% vs its 200-day average ($0.75).
- 52-week range $0.14–$5.67; today's close sits at 32% of that range, 66.3% below the 52-week high.
- SEC filings that day: 8-K.
Oct 8, 2026 — BRTX slides 15.6% to $1.89, a 1-month low
- Closed at $1.89, -15.63% vs the prior close of $2.24. Day range $1.75–$2.18, opened at $2.18.
- Volume was 95.60K shares, 0.4x its 50-day average of 238.31K — lighter than usual.
- Price is +23.2% vs its 50-day average ($1.53) and +152.7% vs its 200-day average ($0.75).
- 52-week range $0.14–$5.67; today's close sits at 32% of that range, 66.7% below the 52-week high.
Oct 7, 2026 — BRTX dips 1.3% to $2.24
- Closed at $2.24, -1.32% vs the prior close of $2.27. Day range $2.05–$2.30, opened at $2.30.
- Volume was 37.80K shares, 0.2x its 50-day average of 251.27K — lighter than usual.
- Price is +49.2% vs its 50-day average ($1.50) and +200.9% vs its 200-day average ($0.74).
- 52-week range $0.14–$5.67; today's close sits at 38% of that range, 60.5% below the 52-week high.
Oct 6, 2026 — BRTX rises 1.3% to $2.27
- Closed at $2.27, +1.34% vs the prior close of $2.24. Day range $2.13–$2.29, opened at $2.20.
- Volume was 79.70K shares, 0.3x its 50-day average of 255.69K — lighter than usual.
- Price is +55.2% vs its 50-day average ($1.46) and +207.3% vs its 200-day average ($0.74).
- 52-week range $0.14–$5.67; today's close sits at 39% of that range, 60.0% below the 52-week high.
Oct 5, 2026 — BRTX jumps 4.7% to $2.24
- Closed at $2.24, +4.67% vs the prior close of $2.14. Day range $2.01–$2.31, opened at $2.16.
- Volume was 85.20K shares, 0.3x its 50-day average of 256.59K — lighter than usual.
- Price is +57.4% vs its 50-day average ($1.42) and +205.7% vs its 200-day average ($0.73).
- 52-week range $0.14–$5.67; today's close sits at 38% of that range, 60.5% below the 52-week high.
Oct 2, 2026 — BRTX slides 5.7% to $2.14, 3 down days in a row
- Closed at $2.14, -5.73% vs the prior close of $2.27. Day range $2.14–$2.43, opened at $2.26.
- Volume was 25.50K shares, 0.1x its 50-day average of 258.82K — lighter than usual.
- Price is +54.6% vs its 50-day average ($1.38) and +194.3% vs its 200-day average ($0.73).
- 52-week range $0.14–$5.67; today's close sits at 36% of that range, 62.2% below the 52-week high.
- That makes 3 straight losses.
BRTX latest news & SEC filings
Every SEC filing by or about BRTX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 11, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 10, 2026 · 8-K/A — Amended current report
Amended current report
- Item 4.01 — Changed its outside auditor.
- Item 8.01 — Reported other events the company considers important.
Sep 2, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 2, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 4.01 — Changed its outside auditor.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 25, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Aug 14, 2026 · NT 10-Q — Notice of late quarterly report
Notice of late quarterly report
Aug 14, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 3, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 24, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 16, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jun 18, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jun 18, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Things to know before you trade BRTX
- Last results release: Nov 12, 2025 (8-K Item 2.02). Previous ones: Aug 12, 2025, May 14, 2025, Mar 27, 2025. Based on that rhythm, the next report is likely around Feb 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.17% (largest 15.6%). That is a volatile stock.
- Liquidity: about 39.61K shares (≈$57.83K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.46 vs a range of $0.14–$5.67 (24% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:20 on Sep 8, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 9, 2026; 8-K Sep 11, 2026; 8-K Sep 2, 2026.
- Share count: 25.48M shares outstanding (May 14, 2026), +239.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Services-Misc Health & Allied Services, NEC.
BRTX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 1.50 | 1.50 | 1.28 | 1.46 | 27.80K |
| Oct 14, 2026 | 1.50 | 1.56 | 1.42 | 1.50 | 18.30K |
| Oct 13, 2026 | 1.70 | 1.71 | 1.44 | 1.59 | 32.40K |
| Oct 12, 2026 | 1.85 | 1.90 | 1.70 | 1.75 | 11.40K |
| Oct 9, 2026 | 1.92 | 1.95 | 1.85 | 1.91 | 18.40K |
| Oct 8, 2026 | 2.18 | 2.18 | 1.75 | 1.89 | 95.60K |
| Oct 7, 2026 | 2.30 | 2.30 | 2.05 | 2.24 | 37.80K |
| Oct 6, 2026 | 2.20 | 2.29 | 2.13 | 2.27 | 79.70K |
| Oct 5, 2026 | 2.16 | 2.31 | 2.01 | 2.24 | 85.20K |
| Oct 2, 2026 | 2.26 | 2.43 | 2.14 | 2.14 | 25.50K |
| Oct 1, 2026 | 2.28 | 2.47 | 2.25 | 2.27 | 21.50K |
| Sep 30, 2026 | 2.26 | 2.39 | 2.26 | 2.33 | 24.90K |
| Sep 29, 2026 | 2.32 | 2.34 | 2.26 | 2.33 | 15.10K |
| Sep 28, 2026 | 2.42 | 2.49 | 2.29 | 2.31 | 49.40K |
| Sep 25, 2026 | 2.55 | 2.68 | 2.44 | 2.55 | 28.50K |
| Sep 24, 2026 | 2.59 | 2.69 | 2.51 | 2.51 | 24.30K |
| Sep 23, 2026 | 2.61 | 2.90 | 2.53 | 2.60 | 85.20K |
| Sep 22, 2026 | 2.72 | 2.93 | 2.50 | 2.55 | 67.00K |
| Sep 21, 2026 | 2.70 | 2.75 | 2.68 | 2.71 | 26.80K |
| Sep 18, 2026 | 2.71 | 2.79 | 2.67 | 2.69 | 17.40K |
About BioRestorative Therapies
BioRestorative Therapies (BRTX) is listed on the Nasdaq and classified by the SEC under “Services-Misc Health & Allied Services, NEC”. Its business address is in MELVILLE, NY. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1505497.
BRTX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Lance Alstodt | President, CEO, COB | Oct 20, 2025 |
| Steven Collier Brown | Director | Jul 24, 2026 |
| Jatinder Dhaliwal | Director | Jun 18, 2026 |
| Katharyn Field | Director | Jun 17, 2026 |
| Mika Grasso | Director | Jun 18, 2026 |
| Esha Randhawa | Director | Jul 30, 2026 |
| Francisco Silva | VP of Research and Development | Oct 20, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lance Alstodt | President, CEO, COB | Oct 20, 2025 |
| Francisco Silva | VP of Research and Development | Oct 20, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BRTX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $359.70K | $-14.24M | -1.58 | $-10.79M |
| Dec 31, 2024 | $401.00K | $-8.98M | -1.16 | $-8.23M |
| Dec 31, 2023 | $145.80K | $-10.42M | -2.47 | $-6.43M |
| Dec 31, 2022 | $119.80K | $-18.49M | -5.11 | $-5.91M |
| Dec 31, 2021 | $46.00K | $-44.30M | — | $-3.33M |
Latest balance sheet: total assets $4.64M, total liabilities $3.67M, cash $3.11M (as of Mar 31, 2026).
BRTX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Nov 12, 2025 | 8-K Item 2.02 (results) | $1.38 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $1.47 |
| May 14, 2025 | 8-K Item 2.02 (results) | $1.71 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $1.83 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $1.54 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Misc Health & Allied Services, NEC
Davita (DVA)Sotera Health (SHC)Fresenius Medical Care AG (FMS)Progyny (PGNY)agilon health (AGL)Viemed Healthcare (VMD)NewGenIvf (NIVF)Park Dental Partners (PARK)Mangoceuticals (MGRX)Cryo Cell International (CCEL)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on BRTX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.